A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

NCT06385821 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

824

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Influenza A
Influenza, Human
Influenza Type B
Flu
Influenza A H3N2
Influenza A H1N1
Influenza Epidemic
Flu, Human
Acute Respiratory Infection
Vaccine Reaction

Interventions

BIOLOGICAL: Grippol Quadrivalent
BIOLOGICAL: Grippol Plus

Sponsor

NPO Petrovax